Torrent Pharmaceuticals Ltd.

Licencing-out dossiers for leading molecules with Patent Expiry in the coming years in the area of CNS
Contract Research including development of dossiers/ DMF
Leading generic player in the Indian Pharmaceutical Market

Activity:

- Contract Manufacturing
- Contract Research
- Licensing & Business Development
- Manufacturing
- Research & Development
- Sales & Distribution

Product / Technology type(s) covered:

- API / chemicals
- Drug delivery
- Generics
- FP (finished products)
- NCE (new chemical entities)
- Pharmaceuticals / Therapeutics
- Prescription drugs (Rx)

Therapeutic targets:

- Arthritis / Rheumato
- Cardiovascular
- Central nervous system
- Cough / Cold
- Dermatology
- Diabetes
- Gastrointestinal
- Infectious Diseases
- Neurology
- Obesity
- Pain
- Urology

Markets Covered

a. HeadQuarter: India

b. Continent(s) active: Asia , Europe , Central/South America , Africa

c. Countries active: India Brazil Russia Germany UK South-Africa Sri-Lanka Zimbabwe Poland Romania Ukraine Lithuania Latvia Vietnam Algeria Phillipines Ghana CzechRepublic

Corporate data:

Number of Employees: 2000

Turnover:

Amount:	Year:	Currency:
110 Mn	2002	US Dollar

Year founded: 1972

Partners / Alliances: TPL exports to more than 25 countries around the world with over 400 regns. Zao Torrent Pharma in Russia, Torrent Do Brasil Ltda in Brazil, Torrent Pharma GmbH in Germany and Torrent Pharma Inc. in USA are the its own subsidiaries. R&D collaboration with William Harvey Research Institute, U.K. & Charterhouse Therapeutics Ltd, UK.